FDA opened transcatheter aortic valve replacement (TAVR) to low-risk patients with the simultaneous approvals of Edwards Lifesciences' | Feature | Heart Valve Technology | Jeff Zagoudis and Dave Fornell, Diagnostic and Interventional Cardiology (DAIC)
Read More